ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 52 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $20,000 | -4.8% | 440 | +4.8% | 0.00% | – |
| Q2 2020 | $21,000 | +200.0% | 420 | +268.4% | 0.00% | – |
| Q1 2020 | $7,000 | 0.0% | 114 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | -22.2% | 114 | -36.7% | 0.00% | – |
| Q3 2019 | $9,000 | -30.8% | 180 | +4.0% | 0.00% | – |
| Q2 2019 | $13,000 | +160.0% | 173 | +203.5% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 57 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -81.8% | 57 | -94.3% | 0.00% | – |
| Q2 2016 | $22,000 | -24.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $29,000 | -12.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $33,000 | -95.5% | 1,000 | -95.0% | 0.00% | -100.0% |
| Q3 2015 | $729,000 | +1556.8% | 20,200 | +1920.0% | 0.01% | – |
| Q2 2015 | $44,000 | +46.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | -99.9% | 1,000 | -99.8% | 0.00% | -100.0% |
| Q4 2014 | $20,768,000 | +60.2% | 408,476 | +24.7% | 0.16% | +43.0% |
| Q3 2014 | $12,962,000 | +33.7% | 327,655 | +45.5% | 0.11% | +31.0% |
| Q2 2014 | $9,696,000 | +24761.5% | 225,169 | +22416.9% | 0.09% | – |
| Q1 2014 | $39,000 | +44.4% | 1,000 | 0.0% | 0.00% | – |
| Q4 2013 | $27,000 | +22.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2013 | $22,000 | +29.4% | 1,000 | 0.0% | 0.00% | – |
| Q2 2013 | $17,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |